Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Gvhd and Relapse Free Survival (GRFS) after Allogeneic Transplantation for Idiopathic Severe Aplastic Anemia: An Analysis from the Saawp Data Quality Initiative Program of EBMT

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-141757

Published: 2020

Journal Articles

Comparison of Different Upfront Transplant Strategies in Multiple Myeloma - a Large Registry Study from Chronic Malignancies Working Party of EBMT

Blood (2019) 134 (Supplement_1): 324.

https://doi.org/10.1182/blood-2019-128795

Published: 2019

Journal Articles

Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT

Blood (2019) 134 (Supplement_1): 4018.

https://doi.org/10.1182/blood-2019-131410

Published: 2019

Journal Articles

Results of Autologous and Allogeneic Transplantation in Patients with Primary Plasma Cell Leukemia: A Large Retrospective Analysis of the Chronic Malignancies Working Party of the EBMT

Blood (2018) 132 (Supplement 1): 3425.

https://doi.org/10.1182/blood-2018-99-113824

Published: 2018

Journal Articles

Prospective Outcomes of Second Line Therapy in Acute Gvhd: Six Month Freedom from Treatment Failure and Day 28 Response in a Multicentre Study

Rohini Radia, MD FRCPath, Arun Alfred, Matthew P. Collin, MD PhD, Maria H Gilleece, MD FRCPath, MB, BSc, FRCP, James E Griffin, BSc (Hons), MBChB (Hons), PhD, Ann E. Hunter, MBBS, FRCP, FRCPath, Hannah Hunter, MB, FRCPath, MRCP, Harpreet Kaur, Nandita Khera, MD, Kavita Raj, MD PhD, Emma Das-Gupta, DM, FRCPath, MRCP, Fiona Louise Dignan, MD, Madan Jagasia, MD MS

Blood (2018) 132 (Supplement 1): 3408.

https://doi.org/10.1182/blood-2018-99-115376

Published: 2018

Journal Articles

Transcriptional Profiles, Lineage Tracing with BRAF-V600E and HLA-DQB2 Expression Support a Model of Blood CD1c+ Cells As Precursors to LCH Lesion CD207+ Cells

Karen Phaik Har Lim, Paul Milne, PhD BSc, Michael Poidinger, PhD, Kaibo Duan, PhD, Howard Lin, Harshal Abhyankar, MS, Daniel Zinn, MD, Olive S. Eckstein, MD, Rikhia Chakraborty, PhD BSc, MSc, Evan Newell, PhD, Miriam Merad, MD, Kenneth L. McClain, MD PhD, Chris Tsz-Kwong Man, PhD, Florent Ginhoux, PhD, Matthew P. Collin, MD PhD, Carl E. Allen, MD PhD

Blood (2017) 130 (Supplement 1): 4218.

https://doi.org/10.1182/blood.V130.Suppl_1.4218.4218

Published: 2017

Journal Articles

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Kile Green, BSc(Hons), Rob Sellar, MD, Laura Jardine, MD, Janice Ward, Paul Ferguson, MD, Pip Nicolson, MD, Kim Pearce, PhD, Venetia Bigley, MD, PhD, Graham Jackson, MD, Sandeep Nagra, MD, Anne M Dickinson, PhD, Kirsty Thomson, MD, Stephen Mackinnon, MD, Charles Craddock, MD, Matthew P. Collin, MD, PhD, Karl S Peggs, MD

Blood (2013) 122 (21): 4540.

https://doi.org/10.1182/blood.V122.21.4540.4540

Published: 2013

Journal Articles

Hematopoietic Stem Cells and Circulating Myelomonocytic Precursors With BRAF-V600E Are Identified In High-Risk Patients and Define LCH As a Myeloid Neoplasia

Karen Phaik-Har Lim, MS, Tricia L Peters, MD, MS, Marie-Luise Berres, MD, Jeremy Price, Hitoshi Takizawa, PhD, Philip Lupo, PhD, M. John Hicks, MD, PhD, DDS, Albert Shih, Stephen James Simko, III, MD, Kenneth Matthew Heym, MD, Venetia Bigley, MD, PhD, Matthew P. Collin, MD, PhD, Markus G. Manz, MD, Kenneth McClain, MD, PhD, Miriam Merad, MD, PhD, Carl E. Allen, MD, PhD

Blood (2013) 122 (21): 103.

https://doi.org/10.1182/blood.V122.21.103.103

Published: 2013

Journal Articles

Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation

Blood (2011) 118 (21): 2045.

https://doi.org/10.1182/blood.V118.21.2045.2045

Published: 2011

Journal Articles

A Novel SNP-Based Method for Assessing Langerhans Cell Chimerism Following Hematopoietic Stem Cell Transplantation in Humans.

A. Yasmine Kirkorian, Matthew P Collin, MD, PhD, Marco Mielcarek, MD, Wandi Zhang, Donna Neuberg, ScD, Catherine J Wu, MD, Miriam Merad, MD, PhD

Blood (2008) 112 (11): 2328.

https://doi.org/10.1182/blood.V112.11.2328.2328

Published: 2008

Journal Articles

Mesenchymal Stem Cells and Fibroblasts Have Similar Immunoregulatory Properties In Vitro but Distinct Gene Expression Profiles: Implications for Cellular Therapy.

Muzlifah A. Haniffa, MBBCh, Xiao N. Wang, MD, Udo Holtick, MD, Daniel C. Swan, PhD, Sarah Bullock, BSc, Anne M. Dickinson, PhD, Catharien M. Hilkens, PhD, Matthew P. Collin, MD, PhD

Blood (2007) 110 (11): 1930.

https://doi.org/10.1182/blood.V110.11.1930.1930

Published: 2007

Journal Articles

Persistent Recipient Antigen-Presenting Cells in Human Hematopoietic Stem Cell Transplantation: Identification of a New Dermal Subset That Outlives Epidermal Langerhans Cells.

Muzlifah Haniffa, MD, Suzanne Alshemali, MD, Sarah Bullock, BSc, Matthew P. Collin, MD, PhD

Blood (2007) 110 (11): 66.

https://doi.org/10.1182/blood.V110.11.66.66

Published: 2007

Journal Articles

The MyD88 Adapter-Like (Mal) Protein Variant Leu 180, a Candidate Polymorphism for Protection Against Graft Versus Host Disease.

Udo Holtick, MD, Peter G. Middleton, PhD, Jane L. Harrold, Ernst Holler, MD, Eliane Gluckman, MD, Ilona Hromadnikova, PhD, Anne M. Dickinson, PhD, Matthew P. Collin, MD,PhD

Blood (2006) 108 (11): 3243.

https://doi.org/10.1182/blood.V108.11.3243.3243

Published: 2006

Journal Articles

CD1a Is a Dimorphic Antigen-Presenting Protein That May Be Mismatched without Increasing the Risk of Graft Versus Host Disease.

Eleanor M. Lanning, Peter G. Middleton, PhD, Anne M. Dickinson, PhD, Ernst Holler, MD, Eliane Gluckman, MD, Ilona Hromadnikova, PhD, Matthew P. Collin, MD

Blood (2005) 106 (11): 1811.

https://doi.org/10.1182/blood.V106.11.1811.1811

Published: 2005

Journal Articles

The Fate of Human Langerhans Cells in Hematopoietic Stem Cell Transplantation.

Matthew P. Collin, MD, Derek N. Hart, MD, Graham H. Jackson, MD, Gordon Cook, MD, James Cavet, MD, Stephen Mackinnon, MD, Anne M. Dickinson, PhD

Blood (2005) 106 (11): 572.

https://doi.org/10.1182/blood.V106.11.572.572

Published: 2005

NARROW

Gvhd and Relapse Free Survival (GRFS) after Allogeneic Transplantation for Idiopathic Severe Aplastic Anemia: An Analysis from the Saawp Data Quality Initiative Program of EBMT

Comparison of Different Upfront Transplant Strategies in Multiple Myeloma - a Large Registry Study from Chronic Malignancies Working Party of EBMT

Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT

Results of Autologous and Allogeneic Transplantation in Patients with Primary Plasma Cell Leukemia: A Large Retrospective Analysis of the Chronic Malignancies Working Party of the EBMT

Prospective Outcomes of Second Line Therapy in Acute Gvhd: Six Month Freedom from Treatment Failure and Day 28 Response in a Multicentre Study

Transcriptional Profiles, Lineage Tracing with BRAF-V600E and HLA-DQB2 Expression Support a Model of Blood CD1c+ Cells As Precursors to LCH Lesion CD207+ Cells

Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study

Hematopoietic Stem Cells and Circulating Myelomonocytic Precursors With BRAF-V600E Are Identified In High-Risk Patients and Define LCH As a Myeloid Neoplasia

Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation

A Novel SNP-Based Method for Assessing Langerhans Cell Chimerism Following Hematopoietic Stem Cell Transplantation in Humans.

Mesenchymal Stem Cells and Fibroblasts Have Similar Immunoregulatory Properties In Vitro but Distinct Gene Expression Profiles: Implications for Cellular Therapy.

Persistent Recipient Antigen-Presenting Cells in Human Hematopoietic Stem Cell Transplantation: Identification of a New Dermal Subset That Outlives Epidermal Langerhans Cells.

The MyD88 Adapter-Like (Mal) Protein Variant Leu 180, a Candidate Polymorphism for Protection Against Graft Versus Host Disease.

CD1a Is a Dimorphic Antigen-Presenting Protein That May Be Mismatched without Increasing the Risk of Graft Versus Host Disease.

The Fate of Human Langerhans Cells in Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only